 OXFORD, United Kingdom and MARLBOROUGH, Mass., Feb. 08, 2021 GLOBE NEWSWIRE -- Oxford Immunotec Global PLC Nasdaq: OXFD the Company, a global, high-growth diagnostics company today announces it has worked with GC MS and MESDIA Co., Ltd. to enter into an MOU to market the research use only T-SPOT Discovery SARS-CoV-2 kit in South Korea. 